Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: CuttingEdge Bio who wrote (2852)	3/16/2020 2:39:52 PM
From: Biotechwantabe	Respond to of 3557

I’m sure they are trying to go ASAP From statement In addition to our Kevzara program, Regeneron is also rapidly advancing a novel antibody cocktail for the prevention and treatment of COVID-19, which we hope to have available for human testing this summer. It would be interesting to know how many critical patients where already on I’ll-6

To: CuttingEdge Bio who wrote (2852)	3/17/2020 3:37:49 AM
From: Miljenko Zuanic	Respond to of 3557

<But still there have to be ways to speed up this overall process. "Late summer" is a long time> They will (may) not have second chance . So, better be effective with first attempt. They may want to test coctail in real world settings....primate infected with live nCoV (at CDC), observe outcome,...before commiting HUGE manufacturing process to bring online clinical trial quantity (maybe even compassionate use). Mid/late summer is ACCEPTABLE time frame. Maybe it is over-promising? REGN staff will need to work very hard for next few months. Hope, they will not be inside outbreak, forcing scientist to work from home perspective. That would be bad! This virus is not going away that easily...second outbreak (few months after first one is contained, winter 2020/21) is very likely scenario...and vaccine can not do trick on their own. At that time, IF one fave effective prophylactic/treatment option is huge advancement!